Prelude Capital Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Prelude Capital Management’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-10,400	Closed	-$178K	–	2389
2021 Q3	$178K	Buy	+10,400	New	+$162K	﹤0.01%	1393

Other funds holding CCXI

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Prelude Capital Management's CCXI Position: Q4 2022 in Review

Prelude Capital Management sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 208,861 shares — an estimated $10.8M sold.

Prelude Capital Management first reported a position in CCXI in Q3 2013 and held it in 13 quarters. The position peaked at $10.8M in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

Prelude Capital Management reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
Prelude Capital Management sold 208,861 ChemoCentryx, Inc. shares in Q4 2022, an estimated $10.8M.
Prelude Capital Management first reported a position in ChemoCentryx, Inc. in Q3 2013 and held it in 13 quarters.
Prelude Capital Management's ChemoCentryx, Inc. position peaked at $10.8M in Q3 2022.
1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Prelude Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.